BioGenes GmbH: Specialized Services in Antibody and Immunoassay Development
BioGenes GmbH is a distinguished German life sciences company, established in 1992 and headquartered in Berlin. The entity operates as an ISO 9001:2015 certified, full-service contract research and development partner, concentrating on providing sophisticated immunological and protein biochemical services to the global pharmaceutical, biotechnology, Contract Manufacturing Organization (CMO), Contract Research Organization (CRO), and in vitro diagnostic (IVD) industries. The company's core mission is to deliver highly customized solutions, with a strong emphasis on quality control and analytical services for biological products throughout the entire drug development pipeline, from drug discovery to commercial manufacturing.
With over three decades of specialized expertise, BioGenes has executed thousands of projects, establishing itself as an internationally recognized and reliable partner. Its business model centers on scientific excellence, transparent processes, and flexible, customer-centric project management. The firm serves a vast customer base globally, maintaining long-term relationships with many of the world's leading biopharma organizations.
Core Competencies and Services
The primary focus of BioGenes is rooted in the highly specialized fields of custom antibody development and immunoassay development, particularly for critical quality control (QC) applications in biopharmaceutical production.
1. Custom Antibody Development
BioGenes provides an expansive range of custom antibody services, tailored to specific project needs, including both routine and highly sophisticated requirements.
* Monoclonal Antibody Development: Custom generation of highly specific monoclonal antibodies for various applications.
* Polyclonal Antibody Development: Production of polyclonal antibodies, often used for immunopurification and assay development.
* Anti-idiotypic Antibody Development: A key specialization, involving the development of antibodies that specifically bind to the antigen-binding site (idiotype) of a therapeutic antibody, which are crucial reagents for Pharmacokinetic (PK) and Immunogenicity assays.
2. Host Cell Protein (HCP) Analysis and Assays
Host Cell Proteins (HCPs) are a category of process-related impurities in biopharmaceuticals that must be rigorously monitored and removed. BioGenes is a widely recognized expert in this area, offering a complete development package.
* Custom HCP ELISA Development: Development of highly sensitive and robust, product-specific Enzyme-Linked Immunosorbent Assays (ELISAs) to monitor HCP clearance during the purification process. This involves antibody generation, assay development, pre-validation, and production.
* HCP Analytical Services: Comprehensive analytical services for HCP coverage and characterization, including advanced techniques like 2D Difference Gel Electrophoresis (2D DIGE), Western Blotting, and subsequent coverage calculation to demonstrate that the custom-developed assay sufficiently detects all relevant HCPs.
3. Immunoassay and Bioanalytical Services
Beyond HCP, BioGenes offers a comprehensive portfolio of general immunoassay and analytical services for different stages of drug development.
* Pharmacokinetic (PK) Assay Development: Development and optimization of assays to measure the concentration of a biotherapeutic drug in biological matrices (e.g., serum, plasma).
* Immunogenicity Assay Development: Development of assays to detect and characterize anti-drug antibodies (ADAs) that may be generated in response to a therapeutic protein, a critical regulatory requirement.
* Immunoassay Production (OEM): Services for the Original Equipment Manufacturer (OEM) production of small and medium-sized lots of finished immunoassay kits, providing a streamlined path for customers to commercialize their diagnostic or QC assays.
Products Offered
In addition to its customized services, BioGenes provides proprietary, off-the-shelf products to the life sciences market.
* Generic Host Cell Protein (HCP) ELISA Kits: The company offers enhanced generic HCP ELISA kits, such as the 360-HCP ELISA kits, specifically designed to detect and quantify HCP impurities from common expression systems. These include kits validated for use with Chinese Hamster Ovary (CHO) cells, E. coli, and Human Embryonic Kidney (HEK293) cells, providing a versatile tool for initial process development and screening.
Please note: This information is generated by AI. For legal use, verify with company sources.
